Industry & Policy News

[Kazinform International News Agency] Under the patronage and in the presence Zaki Nusseibeh, Cultural Adviser to the UAE President and Chancellor of the United Arab Emirates University (UAEU), UAEU inaugurated the Stem Cells Research Centre, the first of its kind in the academic world in the UAE.

[Dewpoint Therapeutics, Inc.] Dewpoint Therapeutics, Inc. announced the nomination of a second development candidate, DPTX3496. DPTX3496 is an oral, small molecule condensate modulator targeting beta catenin to address Wnt-driven colorectal cancer, TNBC, and non-small cell lung cancer.

[Grey Matter Neurosciences (Canada Newswire)] Grey Matter Neurosciences announced that it has licensed advanced focused ultrasound technology developed at Sunnybrook Research Institute. The technology holds transformative potential in the treatment of Alzheimer's and other brain diseases and disorders.

[UCLA Health] Dr. Anne Churchland has been recognized by the National Academy of Sciences for her outstanding advancements in understanding the underlying mechanisms of decision making and sensory-guided behavior.

[OS Therapies, Inc.] OS Therapies, Inc. announced positive data from a Phase IIb clinical trial of OST-HER2 - the Company’s HER2-targeted immunotherapy candidate in the rare pediatric-designated indication of prevention of recurrent, fully resected, lung metastatic osteosarcoma.

[Allogene Therapeeutics, Inc.] Allogene Therapeutics, Inc. announced that the US FDA has cleared its Investigational New Drug application for a rheumatology basket study of ALLO-329, an investigational allogeneic CAR T product.